| 000 | 01625 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514181309.0 | ||
| 264 | 0 | _c20040322 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1170-7690 | ||
| 024 | 7 |
_a10.2165/00019053-200321170-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOrme, Michelle E | |
| 245 | 0 | 0 |
_aThe cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _c2003 |
||
| 300 |
_a1263-76 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Survival _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aKidney Transplantation _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aJurewicz, Wieslaw A | |
| 700 | 1 | _aKumar, Nagappan | |
| 700 | 1 | _aMcKechnie, Tracy L | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 21 _gno. 17 _gp. 1263-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00019053-200321170-00003 _zAvailable from publisher's website |
| 999 |
_c14707843 _d14707843 |
||